79 results
8-K
EX-10.1
INVA
Innoviva Inc
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
, continuing, and irreparable injury to the members of the Company Group for which monetary damages would not be an adequate remedy. Therefore, I hereby agree … or threatened breach of the terms of this Agreement without the necessity of proving irreparable harm or injury as a result of such breach or threatened breach
8-K
EX-99.1
INVA
Innoviva Inc
23 Aug 22
Other Events
4:08pm
the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could … candidates or products that we may develop;
injury to our reputation and significant negative media attention;
- 13 -
withdrawal of clinical trial
SC TO-T
EX-99
INVA
Innoviva Inc
25 Jul 22
Third party tender offer statement
8:34am
and acknowledges that any such violation or threatened violation may cause irreparable injury to the other Party, and that, in addition to any other remedies
8-K
EX-10.1
i10crwkc
12 Jun 20
Departure of Directors or Certain Officers
4:42pm
8-K
EX-10.2
13g818ee 2s74
4 Oct 18
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.1
f4kc8jsvvgod3fo oic
4 Oct 18
Departure of Directors or Certain Officers
5:21pm
8-K
EX-10.1
ihuelva
8 Aug 18
Departure of Directors or Certain Officers
4:44pm
8-K
EX-10.1
gosu7 s3eekegx5qnw
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.2
wu4 1vraxjbquv
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am